Paige AI

FDA-cleared AI pathology platform detecting cancer in digital pathology slides to assist pathologists.

Pricing

$$$

Best for

Enterprise

Classification

AI-Native

Type

Platform Suite

Pricing

$$$

Classification

AI-Native

Type

Platform Suite

See full details ↓

What it does

Paige AI is an AI-native digital pathology company - developing FDA-cleared AI algorithms that analyze whole slide images to detect cancer and assist pathologists in diagnosis. Paige Prostate was the first FDA-authorized AI for pathology. AI capabilities include AI prostate cancer detection that identifies suspicious regions in prostate biopsy slides with high sensitivity, AI breast cancer detection and tumor quantification in breast pathology slides, intelligent slide triage that prioritizes which cases need urgent pathologist attention, AI-powered biomarker analysis that identifies predictive biomarkers for treatment selection, computational pathology tools for pharmaceutical clinical trials, and whole slide image analysis infrastructure for pathology AI development.

Why AI-NATIVE

Paige AI is AI-native - FDA-cleared AI algorithms that autonomously detect cancer in pathology slides represent genuinely AI-native medical diagnostic capabilities.

Best for

Enterprise

Large academic medical centers and health system pathology labs use Paige AI for AI-assisted pathology - FDA-cleared detection improving diagnostic sensitivity and prioritizing pathologist workflow.

Limitations

FDA clearance limited to specific cancer types and indications

Paige AI's FDA clearances cover specific indications — pathology labs must verify current clearance status for each clinical application before deployment.

AI findings require pathologist confirmation

Paige AI is a decision support tool — every AI finding requires pathologist review and confirmation before clinical use and patient communication.

Requires digital pathology scanning infrastructure

Paige AI works on digitized whole slide images — pathology labs must have or implement digital scanners before AI analysis is possible, representing significant infrastructure investment.